e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Novel strategies for the management of asthma, COPD and airway infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effects of bronchodilators in patients with tuberculosis-destroyed lung and chronic airflow obstruction
Jung Seop Eom (Busan, Republic of Korea), Jung Seop Eom, Hye Yun Park, Min Ki Lee, Min Ji Kim
Source:
International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Session:
Novel strategies for the management of asthma, COPD and airway infections
Session type:
Thematic Poster Session
Number:
3941
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jung Seop Eom (Busan, Republic of Korea), Jung Seop Eom, Hye Yun Park, Min Ki Lee, Min Ji Kim. The effects of bronchodilators in patients with tuberculosis-destroyed lung and chronic airflow obstruction. Eur Respir J 2015; 46: Suppl. 59, 3941
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Evaluation of bronchodilator responses in patients with "irreversible" emphysema
Source: Eur Respir J 2001; 18: 914-920
Year: 2001
Impulse oscillation respiratory reactance and airway reversibility in chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Airway resistances deteriorate following spirometry in asthma and COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Lung hyperinflation in COPD: the impact of pharmacotherapy
Source: Eur Respir Rev 2006; 15: 85-89
Year: 2006
Therapeutic saline inhalation: effects on lung function and dyspnoea in patients with chronic obstructive airway diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 484s
Year: 2001
Spirometry to detect and manage chronic obstructive pulmonary disease and asthma in the primary care setting
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-36-7, page=1
Year: 2005
Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016
Hemodynamic effects of inhaled fenoterol and ipratropium in patients with obstructive pulmonary diseases
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Decametoxine influence on bronchial hyperreactivity in patients with bronchial asthma
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Small airway abnormalities in elderly asthmatics with fixed airflow obstruction vs. COPD: High-resolution CT and pulmonary functions
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Lung comparative function in COPD patients and in patients with chronic airflow obstruction due to tuberculosis lung disorder
Source: Eur Respir J 2006; 28: Suppl. 50, 130s
Year: 2006
Chronic airways obstruction - lung function and dyspnea
Source: Eur Respir J 2004; 24: Suppl. 48, 516s
Year: 2004
Dynamic hyperinflation and pulmonary inflammation: a potentially relevant relationship?
Source: Eur Respir Rev 2006; 15: 68-71
Year: 2006
Hypoxemia, symptoms and bronchial obstruction in asthmatic children seen in a lung function laboratory
Source: International Congress 2015 – Paediatric respiratory physiology
Year: 2015
Bronchodilator responsiveness in patients with COPD
Source: Eur Respir J 2008; 31: 742-750
Year: 2008
Pulmonary response to salbutamol inhalation using dynamic OE-MRI in patients with asthma
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013
Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV
1
and FEV
1
in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept